Methylene Blue for POTS with Dr. Scott Sherr

Dr. Scott Sherr discusses the use of Methylene Blue, an FDA-approved compound originally used as a dye and antimicrobial, as a potential treatment for POTS patients experiencing energy deficits and brain fog. He explains that Methylene Blue can enhance mitochondrial function, thus improving energy production and detoxification, while also potentially aiding in reducing nitric oxide-induced vasodilation which is common in POTS. Methylene Blue can be administered in various forms, including oral and buccal troches, allowing for different absorption rates. Dr. Sherr emphasizes the importance of quality control due to potential contamination with heavy metals, and suggests starting with low doses to monitor individual responses and avoid potential interactions with other medications. Some potential symptoms of using this compound include detoxification effects like headaches or mild GI distress. Dr. Sherr highlights that while Methylene Blue showed benefits in reducing symptoms for some POTS patients, it should be considered part of a broader health optimization strategy rather than a standalone solution.